Dyne Therapeutics, Inc. (DYN) Insider Trading

Name: Dyne Therapeutics, Inc. (DYN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 8, 2026): Friedl-Naderer Johanna (Chief Commercial Officer): Sale of 900 shares, $21.9K.

Get alerted when insiders trade DYN

Email address

Loading company data...

Beta

Loading company details...

Beta